The anatomic pathology market size is expected to reach US$ 21,398.45 million by 2031 from US$ 12,692.48 million in 2023. The market is estimated to record a CAGR of 6.7% from 2023 to 2031.
Executive Summary and North America Anatomic Pathology Market Analysis:
The anatomic pathology market in North America is segmented into the US, Canada, and Mexico. North America is one of the significant markets for anatomic pathology. The growth of the market in this region is attributed to the growing prevalence of cancer, increasing government initiatives for screening cancer patients, rising focus on efficient disease diagnosis, and surging need for advanced healthcare systems. Moreover, increasing research and development efforts undertaken by the market players, coupled with product launches, are likely to drive the growth of the anatomic pathology market in North America during the forecast period.
North America Anatomic Pathology Market Strategic Insights
Key segments that contributed to the derivation of the anatomic pathology market analysis are product and services, application, and end user.
- Based on product and services, the North America anatomic pathology market is segmented into services, instruments, and consumables. The instruments held the largest share of the market in 2023. The services segment is further sub segmented into histopathology and cytopathology. The instruments segment is further sub segmented into microtomes and cryostat, automatic stainer's, tissue processors, and others.
- By application, the North America anatomic pathology market is segmented into disease diagnosis, drug discovery and development and others. The disease diagnosis segment held the largest share of the market in 2023.
- By end user, the North America anatomic pathology market is segmented into hospitals, research laboratories, diagnostic laboratories, and others. The hospitals segment held the largest share of the market in 2023.
North America Anatomic pathology market Outlook
Small and big companies operating in the anatomic pathology market are increasingly adopting various strategies such as geographic expansion, new product launches, and technological advancements to boost their revenues. A few recent developments in the anatomic pathology market are mentioned below:
- In May 2024, Quest Diagnostic and PathAI entered a multifaceted collaboration to accelerate the adoption of digital and AI pathology innovations to improve quality, speed, and efficiency in diagnosing cancer and other diseases. Under the terms of this definitive agreement, Quest will acquire select assets of PathAI Diagnostics, the business of PathAI that provides digital and anatomic pathology laboratory services.
- In April 2024, Medline became the distributor of products of Epredia, a member of PHC Group. Epredia provides solutions for precision cancer diagnostics and tissue diagnostics in the anatomical pathology field. Through this agreement, Medline offers anatomical pathology products from Epredia to laboratories and customers, thus expanding Medline's extensive portfolio of lab products, devices, and equipment.
- In April 2024, StatLab Medical Products acquired Scientific Device Laboratory, a Chicago-based manufacturer of printed diagnostic slides and a variety of consumables and kits for the anatomic pathology and microbiology markets.
- In March 2024, StatLab Medical Products acquired Poly Scientific R&D ("Poly Scientific"), a US-based manufacturer and supplier of high-quality pathology stains, reagents, tissue controls, and paraffin for anatomic pathology laboratories. Because of this acquisition, StatLab's core manufacturing capabilities, including tissue controls, were expanded, further improving its position as a manufacturer of anatomic pathology consumables while broadening its market presence.
- In February 2024, Hologic Inc received the US Food and Drug Administration (FDA) approval for Genius Digital Diagnostics System, a digital cytology system that delivers next-gen technology for pap testing. This product is set to launch in the US in 2024. Genius Digital Diagnostics System is already sold in Europe, Australia, and New Zealand.
Therefore, the rise in strategic initiatives by market players boosts the growth of the anatomic pathology market.
North America Anatomic Pathology Market Country Insights
Based on country, the North America anatomic pathology market comprises the US, Canada, and Mexico. The US held the largest share in 2023.
In the US, cancer has a significant impact on society. A few common cancer types in the country are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, and liver cancer. As per the National Cancer Institute, in 2021, ~17.43 individuals were living with cancer at any site in the US. The number of cancer survivors is projected to reach 22.2 million by 2030. This mounting prevalence of cancer cases is expected to increase the demand for pathologic diagnostic tests such as biopsies, fine-needle aspiration (FNA), genetic testing, and other novel techniques. Moreover, there has been unprecedented growth in innovative and improved medical technologies in the US in recent years. This growth resulted in the development of advanced medical devices in the healthcare industry. Players operating in the US anatomic pathology market continuously focus on the development of innovative and convenient instruments and consumables for pathological procedures. In November 2023, Illumina Inc., US, a global leader in DNA sequencing and array-based technologies, introduced TruSight Oncology 500 ctDNA v2 (plate number 1 ctDNA v2), a new version of its distributed liquid biopsy assay that allows comprehensive noninvasive genomic profiling of circulating tumor DNA from blood, complementing tissue-based testing. In 2020, F. Hoffmann-La Roche received the US Food and Drug Administration (FDA) approval for the expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer. Thus, factors such as the high prevalence of cancer, strong presence of some major players, and availability of high-quality infrastructure for hospitals and clinical laboratories bolster the growth of the anatomic pathology market in the US.
North America Anatomic Pathology Market Report Highlights
| Report Attribute | Details |
| Market size in 2023 | US$ 12,692.48 Million |
| Market Size by 2031 | US$ 21,398.45 Million |
| CAGR (2023 - 2031) | 6.7% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product and Services
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
Some of the key players operating in the market include F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
North America Anatomic Pathology Market Research Methodology :
The following methodology has been followed for the collection and analysis of data presented in this report:
- Secondary Research
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
- Company websites, annual reports, financial statements, broker analyses, and investor presentations.
- Industry trade journals and other relevant publications.
- Government documents, statistical databases, and market reports.
- News articles, press releases, and webcasts specific to companies operating in the market.
Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
- Primary Research
The Insight Partners’ conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:
- Validate and refine findings from secondary research.
- Enhance the expertise and market understanding of the analysis team.
- Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
- Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
- External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
North America Anatomic Pathology Market Country and Regional Insights
